Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-2

Pralmorelin, Growth Hormone Releasing Peptide-2, KP-102

Quick Stats
Studies 230
Trials 1
Score 3
1994 pubmed 139 citations

GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats.

Deghenghi. R R; Cananzi. M M MM; Torsello. A A; Battisti. C C; Muller. E E EE; Locatelli. V V

Key Findings

  • Hexarelin (His‑D‑2Me‑Trp‑Ala‑Trp‑D‑Phe‑Lys‑NH2) rapidly raises GH levels in conscious 10‑day‑old rats.
  • In anesthetized adult male rats, intravenous Hexarelin and GHRP‑6 produce peak GH spikes within 10 minutes, with similar potency.
  • Subcutaneous Hexarelin produces a longer‑lasting GH surge and is slightly more effective than GHRP‑6.

Practical Outcomes

  • For biohackers, Hexarelin appears to be a potent GH‑releasing peptide that may work as well as GHRP‑6 and could offer a longer effect when given subcutaneously. However, the evidence is limited to rats, so human dosing, safety, and efficacy remain unverified. Use this data as a proof‑of‑concept rather than a ready‑to‑use protocol.

Summary

The study shows that Hexarelin, a synthetic peptide similar to GHRP‑2, strongly triggers growth hormone (GH) release in both newborn and adult rats, working as well as the known peptide GHRP‑6 and lasting a bit longer when injected under the skin.

Abstract

In recent years several synthetic peptides have been shown to be active in inducing GH secretion in different mammalian species. Among them GHRP-6, GHRP-1 and GHRP-2 have demonstrated high effectiveness and high selectivity in stimulating GH release. In the present paper we report studies on the GH-secreting properties of a GHRP analog in which Trp was substituted with the chemically more stable 2-Methyl-Trp. In studies performed in conscious 10-day old rats, the hexapeptide Hexarelin (His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH2) resulted very active in stimulating GH secretion. In anesthetized adult male rats, i.v. administration of GHRP-6 or Hexarelin elicited prompt GH release with peak GH levels occurring within 10 min At all the doses tested, the 2 peptides possessed similar effectiveness in stimulating GH release. Hexarelin given s.c. elicited a long-lasting GH release and was slightly more effective than GHRP-6. In conclusion, these findings indicate that Hexarelin is a highly effective GH releaser and might represent a valuable diagnostic and/or therapeutic tool in clinical practice.

Study Information

Provider

pubmed

Year

1994

DOI

10.1016/0024-3205(94)00510-9

Citations

139

References

12